「da」の検索結果
130件：46～50件目を表示
-
tear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumify” (OTC drug req...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
mbination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a partial change in the marketing authorizatio...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904_0.pdf -
mbination eye drops Senju Pharmaceutical Co., Ltd. (Head Office: Osaka City, President: Shuhei Yoshida) announced today that it has obtained approval for a partial change in the marketing authorizatio...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
tear LUMIFY” Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumify” (OTC drug req...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
Overseas Activities | SENJU Pharmaceutical
al activities with a view to the future of pharmaceuticals, transcending national and corporate boundaries. As we enter the era of globalization, our overseas activities are now diverse. In addition t...
http://www.senju.co.jp/english/global/